Serial tracheal aspirate samples were obtained for determination of lecithin/sphingomyelin (US) ratios from 47 term infants in respiratory failure. Phospholipids were extracted with Foich solution (chloroform:methanol, 2:1 by vol) and analyzed by HPLC with use of a silica column and a mobile phase of acetonitrile:methanol:water (48:31: 21, by vol). Surfactantlalbumin (S/A) ratios were determined with the TDx Fetal Lung Maturity Assay#{174} (Abbott Labs). US ratios increased significantly over time in all patients (F = 19.42, P <0.0001). The S/A ratio correlated with the US ratio (r = 0.554, P <0.001). This study suggests that postnatal surfactant deficiency in term newborns with respiratory failure is a component of the newborn's lung injury.
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In 1959, Avery and Mead recognized that hyaline membrane disease in the premature infant is the result of a primary surfactant deficiency (1) . In the past 5 years, surfactant replacement has become a standard form of therapy for hyaline membrane disease and has led to the investigation of the possible role of surfactant deficiency in other types of neonatal respiratory failure. Secondary deficiency of surfactant has been demonstrated in meconium aspiration syndrome, with inhibition of pulmonary surfactant activity occurring at meconium concentrations much lower than those required for inhibition by plasma protein or blood cell components (2, 3) . Development of pneumonia in infants with sepsis can result in leakage of fluid into the alveoli and interstitium, with destruction of lung surfactant (4) . Damage to the alveolar capillary barrier as a result of mechanical ventilation and hyperoxia alone can result in cell necrosis with protein leak, pulmonary edema, or hemorrhage; such protein leak can result in significant alteration of surfactant function (5, 6) . Cardiopulmonary bypass has also been shown to alter surfactant activity in children (7). Significant intra-and interpatient variability is seen production. The goal of this study was to use HPLC to determine serial tracheal aspirate lecithin/sphingomyelin (US) ratios in a population of term newborns with respiratory failure.6 A further goal of the study was to correlate these data with the patients' lung compliance (CL) findings and to evaluate the relation of the TDx surfactantlalbumin (S/A) assay (TDx Fetal Lung Maturity Assay#{174}; Abbott Labs., Abbott Park, IL) to the US ratios in the same population of infants.
Subjects and Methods Patients
The 2-year trial was designed as a prospective investigation with a randomized, double-blinded approach (9). The study protocol was approved by the Children's National Medical Center Institutional Review Board, and informed parental consent was obtained for all enrolled patients. We studied consecutive infants with persistent pulmonary hypertension of the newborn who met our medical center's criteria for extracorporeal membrane oxygenation (ECMO) and were treated with ECMO (10). We excluded infants who had received previous exogenous surfactant and infants with congenital diaphragmatic hernia. ECMO involves the use of a cardiopulmonary bypass circuit, which oxygenates the infant's blood and eliminates CO2 while allowing the lungs time to heal (11) . This population was selected for measurement of US ratios because infants on ECMO have previously been shown to have surfactant deficiency (12) This technique was compared with the more-often-used extraction procedure for amniotic fluid (involving a mixture of equal volumes of fluid and methanol, followed by the addition of chloroform equal to the aqueous phase), and found to yield no significant difference in recovery.
Chromatography. and investigators participating in the study were not permitted to assist with drug administration.
The infants' beds were screened from bedside personnel during dosing, and tinfoil was wrapped around the end of the endotracheal tubes after drug delivery.
Sample Collection
Tracheal aspirates were collected before surfactant administration (pre) and daily until the infant was removed from bypass. For analysis purposes, we used the samples collected before surfactant administration (pre), on the median day on bypass (mid), and on the day of removal from bypass (last). Tracheobronchial aspiration was performed by instilling a total of 3 mL of 9 g/L NaC1 in 0.5-mL aliquots into the endotracheal tube. After each 1-mL aliquot of saline, the baby was hand-ventilated to disperse the saline solution, and the trachea was suctioned via a catheter slightly beyond the tip of the endotracheal tube. Secretions were collected into a pediatric Leuken trap; the suction catheter was then rinsed with 1 mL of saline into the collection trap to remove secretions adhering to the inside of the suction catheter. Samples were immediately placed on ice, vortex-mixed, and then centrifuged at 950g, 4 #{176}C, for 5 mm. The cell pellet was discarded and the clear supernate saved for determination of the US and S/A ratios. Table 1 . DistrIbution of diagnostic categories between treatment and control groups.
Gestation
The role of centrifugation in the measurement of amniotic fluid has been previously described (13) . Intact particles representative of fetal lung surfactant precipitate at very low g forces, resulting in removal of as much as 20-40% of the surfactant in amniotic fluid. The extent of their removal by centrifugation can therefore result in alteration of US ratio measurements. We measured variation in the mean lecithin peak area, the mean sphingomyelin peak area, and the US ratios when samples were centrifuged at 950g vs not centrifuged.
Surfactant recovery with centrifugation averaged 96.7% of the amount recovered from uncentrifuged samples. Various characteristics of the media, such as viscosity, composition, and concentration, might have contributed to the higher recovery of surfactant from tracheal aspirate fluid. tively, and US ratios were computed from peak areas by means of the Beckman computerized integrator (Fig. 1) The precision study of a series of five consecutive runs within a day gave a CV of 8.6% was used to compare US and S/A ratios in surfactant vs control infants and to evaluate changes across time. An additional factor assessed in the S/A ANOVA was the effect of supplementary albumin. Simple linear regressions of S/A vs US, and US or S/A vs CL, were also performed. For these regressions, S/A measurements were evaluated separately for samples to which human albumin was added. To normalize the distribution and stabilize the variance, we used the natural log transformation of US and S/A for all analyses. Significance was assessed at a = 0.05, and only patients with complete data were included in the repeated-measures ANOVA.
Results
Twenty-five patients were enrolled in the surfactant group and 22 in the control group. The two groups were similar with respect to gender, gestational age, birth weight, Apgar scores, age at ECMO, and hours of intubation before ECMO; arterial blood gas values and ventilator settings were also similar before ECMO. Diagnostic categories were evenly distributed between the groups, with the most common diagnosis being meconiuni aspiration syndrome (Table 1) . with complete sets of data (pre-, mid-and last-day samples). Of these sets, 23 were in the surfactant group and 21 were in the control group. Increases in US ratios correlated with increases in CL (r = 0.345, P <0.001). There were no differences in the US ratios between surfactant and control groups (Fig. 2) and no difference among diagnostic groups (Fig. 3) .
A total of 87 aspirates was also analyzed by TDx methodology for the determination of S/A ratios, with
Time of Sample   Fig. 3 . The natural logarithm of L'S before surlactant (pre), on the median day on ECMO (midl, and on the day of decannulation (last) for different diagnostic categories. Data are displayed as mean + SD; no significant differences were found among diagnostic groups. Abbreviations as in Table 1. values ranging from 3.2 to 160 mg/g. Samples obtained from 12 infants did not require the addition of albumin; samples from 13 infants did, because of low albumin content. The natural logarithms of S/A ratios for infants with complete sets of data (pre-, mid-, and lastday samples), evaluated by a two-way repeated-measures ANOVA, were significantly greater in the surfactant group than in the control group (F = 8.64, P = 0.0007, Fig. 4 ). This grouping factor was also significant (F = 7.27, P = 0.0135). Untransformed S/A ratio data for infants with pre-, mid-, and last-day samples are summarized in Table 3 . For the 12 sets of samples to which albumin did not need to be added, 5 belonged to the surfactant group and 7 to the control group. For the 13 sets of samples to which albumin was added, 8 belonged to the surfactant group and 5 to the control group.
For those samples to which albumin was not added (n = 44), S/A increased significantly as US ratios increased (r = 0.582, P <0.001). With the addition of albumin (n = 43), S/A ratios also increased significantly as US increased (r = 0.554, P <0.001, Fig. 5 ) and as CL increased (r = 0.552, P <0.001). For these correlational studies, all available samples were included in the analyses.
Discussion
In our study, tracheal aspirate US ratios obtained from full-term infants in respiratory failure were initially low and then increased significantly over time in both surfactant and control groups, with no difference between the two treatment groups. Measurement of an amniotic fluid US ratio has been extensively used as an obstetrical tool for many years, and continues to be one of the most accurate predictors of prenatal pulmonary maturity (17, 18) . Determination of postnatal pulmonary maturity in premature infants by measuring tracheal aspirate US ratios by HPLC has also been reported by D'Costa et al., with ratios ranging from 3 to >100 (19) . All infants with Data are displayed as mean + SD. Overall, S/A ratios were significantly greater in the surfactant group than In the control group (P 0.025). However, it is difficult to achieve complete and simultaneous separation of all phospholipids in a timely manner by HPLC. Analysis of the other phospholipids was not included in our study. We found a modification of the HPLC procedure established by Jungawala and later clinically validated by D'Costa et al. (14, 15) to be suitable for achieving our goal of determining US ratios in a timely manner. The mobile phase modification significantly shortened the retention times of both lecithin and sphingomyelin, thereby providing sharper peaks and enabling quantification of peak areas in small volumes (500 p.L) of tracheal aspirate samples. It involved routine HPLC equipment and rendered reproducible data in <6 mm from time of injection. A limitation of this procedure, however, is the inability of the HPLC to accurately quantifr lecithin. With low-wavelength detection, the carbon double bonds in the fatty acid moieties of unsaturated phospholipids produce greater signals than the carbonyl groups of saturated dipalmitoyl lecithin, the main component of lecithin. Though saturated dipalmitoyl lecithin absorbs in the ultraviolet spectrum and gives a measureable peak area, ultraviolet detection monitors the changes in both the unsaturated and saturated lecithins. The inability to predict the ratio of unsaturated to saturated compounds therefore prohibits the method from being accurately standardized. As a result, lecithin could not be quantified in absolute terms (15 
